No new technologies will be added to MedTech Funding Mandate in 2023/24

01

Dec 2022

In November 2022, NHS Accelerated Access Collaborative decided not to add new technologies to MedTech Funding Mandate (MTFM) in 2023/24. Instead, Integrated Care Systems (ICSs) are asked to prioritize the appropriate adoption of eleven currently supported technologies where this has not yet occurred. This decision was made to ensure that the MTFM does not overburden the sector while it continues to recover from the impacts of COVID-19 and embeds ICSs and the new commissioning relationships which underpin system working. The Innovation, Research, and Life Sciences group, along with NICE, NHS Supply Chain, and the Academic Health Science Network (AHSN), will continue to support adopting current MTFM technologies.

The MTFM launched on April 01, 2021, to support NICE-approved and cost-saving devices, diagnostics, and digital products. It is mandatory for commissioners and providers to implement technologies included in MTFM. The scheme is reviewed annually. 

Technologies must meet the following criteria to be supported:

  • Are effective: demonstrated through positive NICE Medical Technology Guidance (MTG) or Diagnostic Guidance (DG), published by June 30;
  • Are cost-saving within three years of implementation: as demonstrated by NICE modeling and published in a NICE resource impact template;
  • Are affordable to the NHS: the NICE budget impact analysis total costs should not exceed £20 million in any of the first three years.

See more information here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

Tags

The latest related news

24

Jan 2023

In December 2022, NHS England launched a consultation on the preliminary 2023/25 NHS Payment Scheme, which is set for two years and will replace the National Tariff Payment System from April 2023. Two new cardiovascular categories (antibacterial envelope, mitral valve repair and replacement devices) are proposed for inclusion in the 2023/24 High Cost Device List (will be updated and reissued for 2024/25). The deadline for comments submission is January 27, 2023.

Read more

20

Jan 2023

In December 2022, the National Institute for Health and Care Research (NIHR) in England released six MedTech-related reports in its Health Technology Assessment (HTA) Journal, which concerned laser therapy in diabetic macular oedema, EarlyCDT Lung blood test, video-assisted thoracoscopic or open lobectomy, urethral slings for stress urinary incontinence, placental growth factor (PlGF) and sFlt-1 tests, and photobiomodulation in the management of oral mucositis. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.

Read more

17

Jan 2023

On December 23, 2022, NHS England published a preliminary 2023/25 NHS Payment Scheme and launched a consultation. NHS Payment Scheme will replace the National Tariff Payment System from April 1, 2023. The deadline for comments submission is January 27, 2023.

Read more

12

Jan 2023

In December 2022, the National Institute for Health and Care Excellence (NICE) published one new Medical Technologies Guidance (Memokath 051 Ureter stent for ureteric obstruction) and one MedTech Innovation Briefing (PromarkerD). Also, two new clinical guidelines were published, and one was updated.

Read more

09

Jan 2023

In December 2022, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclatures for private payers in England, published Bulletin 187 with changes to be implemented in procedural classification no later than February 8, 2023. Five new procedure codes were introduced concerning orthopedic, surgical procedures, and men’s health. No changes were made to the diagnostic schedule.

Read more